MG
Meditor Group Portfolio holdings
AUM
$48.1M
This Quarter Return
-16.31%
1 Year Return
+38.67%
3 Year Return
+41.15%
5 Year Return
+72.2%
10 Year Return
+1,065.64%
AUM
$359M
AUM Growth
+$359M
(-19%)
Cap. Flow
-$7.56M
Cap. Flow
% of AUM
-2.1%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Exelixis
EXEL
|
$4.64M |
| 2 |
Alkermes
ALKS
|
$2.92M |
Sector Composition
| 1 | Healthcare | 93.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Exelixis
EXEL
$10.1B
| $253M | 70.43% | 12,610,540 -231,258 | -2% | -$4.64M |
|
2
Esperion Therapeutics
ESPR
$448M
| $69.7M | 19.39% | 2,679,835 | – | – |
|
3
iShares MSCI India ETF
INDA
$9.17B
| $12.9M | 3.58% | 320,000 | – | – |
|
|
4
Alkermes
ALKS
$4.78B
| $12M | 3.35% | 603,790 -146,210 | -19% | -$2.92M |
|
5
WisdomTree India Earnings Fund ETF
EPI
$2.86B
| $11.7M | 3.25% | 400,000 | – | – |
|